Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Moderna Therapeutics invites an Associate Director HEOR to lead local evidence generation supporting pricing, reimbursement, and market access in Canada. You will oversee external partners, develop value dossiers, and contribute to global HEOR programs while aligning with clinical development, marketing, and pricing teams.
The role requires a PhD/clinical degree with master’s in a related field and 7+ years in HEOR. A Canadian work authorization and strategic leadership are essential.
In this role, you will support the local generation and adaptation of data, evidence and key HEOR deliverables for Moderna products supporting pricing and reimbursement, vaccine recommendations, tender and contracting and institutional customer engagement in Canada. This role leads local HEOR evidence generation and adaptation activities in Canada and provides strategic oversight of external research partners supporting economic modelling, evidence synthesis, value assessment, vaccine recommendation, and pricing activities. The Associate Director HEOR will drive the execution of evidence generation and communication plans and develop tailored evidence partnerships to address stakeholder needs. They will work on launch vaccines and pipeline products in close collaboration with Market Access and Pricing, Marketing, Clinical Development and Medical colleagues. This position reports to the Executive Director, Global HEOR with dotted line to the local Market Access Director.
At Moderna, we believe that when you feel your best, you can do your best work. That’s why our global benefits and well‑being resources are designed to support you—at work, at home, and everywhere in between.
The benefits offered may vary depending on the nature of your employment with Moderna and the country where you work.
The salary range for this role is $196,650.00 - $217,350.00. This range reflects the minimum and maximum base pay we expect to pay for this position based on our current compensation structure. The actual base pay offered to each employee is determined with due diligence, taking into account factors such as relevant experience, skills, qualifications, education, performance, and business requirements. We regularly review pay ranges and individual compensation to ensure competitiveness with the external market and to maintain internal equity in alignment with our company’s compensation and pay‑transparency principles. The successful candidate may be eligible for an annual discretionary bonus, other incentive compensation, or an equity award, subject to applicable plan eligibility criteria and individual performance. Please note that this information is provided for transparency and compliance purposes. It does not constitute a contractual commitment or guarantee of a specific rate of pay.
Since our founding in 2010, we have aspired to build the leading mRNA technology platform, the infrastructure to reimagine how medicines are created and delivered, and a world‑class team. We believe in giving our people a platform to change medicine and an opportunity to change the world. By living our mission, values, and mindsets every day, our people are the driving force behind our scientific progress and our culture. Together, we are creating a culture of belonging and building an organization that cares deeply for our patients, our employees, the environment, and our communities. We are proud to have been recognized as a Science Magazine Top Biopharma Employer, a Fast Company Best Workplace for Innovators, and a Great Place to Work in the U.S. As we build our company, we have always believed an in‑person culture is critical to our success. Moderna champions the significant benefits of in‑office collaboration by embracing a 70/30 work model. This 70% in‑office structure helps to foster a culture rich in innovation, teamwork, and direct mentorship. Join us in shaping a world where every interaction is an opportunity to learn, contribute, and make a meaningful impact.
Moderna is a smoke‑free, alcohol‑free, and drug‑free work environment. Moderna is a place where everyone can grow.
Moderna is committed to equal opportunity in employment and non‑discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry or citizenship, ethnicity, disability, military or protected veteran status, genetic information, sexual orientation, marital or familial status, or any other personal characteristic protected under applicable law. We consider qualified applicants regardless of criminal histories, consistent with legal requirements.
We’re focused on attracting, retaining, developing, and advancing our employees. By cultivating a workplace that values diverse experiences, backgrounds, and ideas, we create an environment where every employee can contribute their best.
Moderna is committed to offering reasonable accommodation or adjustments to qualified job applicants with disabilities. Any applicant requiring an accommodation or adjustment in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should contact the Accommodations and Adjustments team at leavesandaccommodations@modernatx.com.
At Moderna we are pioneering the development of a new class of drugs made of messenger RNA (mRNA). This novel drug platform builds on the discovery that modified mRNA can direct the body’s cellular machinery to produce nearly any protein of interest, from native proteins to antibodies and other entirely novel protein constructs that can have therapeutic activity inside and outside of cells. We have a clear mission to propel the field of mRNA science forward and deliver new medicines to patients and a unique vision for how to achieve this mission.
Our Mission: To deliver on the promise of transformative messenger RNA (mRNA) science to bring new medicines to patients.
Our Vision: To unlock the potential of mRNA by establishing an ecosystem of teams and partners that will work together to develop the broadest possible array of drugs, across diverse therapeutic areas and routes of administration, for serious diseases that are not treatable today.